The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
The UK government has set out its first nationwide plan to address ‘forever chemicals’ (PFAS), outlining new monitoring, research and potential regulatory limits to protect public health and the environment.
As the temperatures continue to rise, we all need to be aware of the dangers of our sun and how to keep safe in hot weather, especially looking out for those most vulnerable.
Paul Christie, Co-Founder and CEO of Tachmed, examines the benefits of a more joined-up approach in health and welfare spending to combat threats to global health.
Cardiac health and AI: A momentous collaboration between healthcare organizations in the UK and the US unveils the Veterans Cardiac Health and AI Model Predictions (V-CHAMPs) Challenge.
Half the British public does not believe care homes are capable of providing their loved ones with adequate care, and yet social care reform continues to lose out.
A recent study published in the British Journal of Pharmacology has shed light on the association between excessive salt consumption and cognitive impairment resulting from hypertension.
Medical breakthroughs are quickly being accessed through a ground-breaking initiative, providing manufacturers and innovators with all-encompassing collaborative support.
Florida Atlantic University and CINVESTAV, Mexico City, conducted a ground-breaking study exploring the effects of long-term running on a network of adult-born neurons.
Researchers from Denmark have developed a cutting-edge artificial intelligence (AI) framework that outperforms human emergency call-takers in the field of stroke identification
This ground-breaking system...
Dr Charlotte Lennox from the University of Manchester reports on the main findings of her research and argues that children in custodial settings were an invisible group during the COVID-19 pandemic, in this second of a two-part series.
